Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience

ConclusionImmune checkpoint inhibition was relatively well tolerated in a cohort of pediatric patients spanning several CNS tumor diagnoses. Results from prospective clinical trials will be critical to inform clinical decisions.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research